Try our Advanced Search for more refined results
June 25, 2018
Astellas Pharma Inc. et al v. Aurobindo Pharma Limited
Case Number:
1:18-cv-00932
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
June 26, 2018
Aurobindo Infringing Bladder Drug Patent, Astellas Says
Astellas Pharma on Monday accused Aurobindo Pharma Ltd. in Delaware federal court of infringing one of its patents covering the overactive bladder medication VESIcare by applying to make its generic version of the medication.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login